Abstract: The present invention is directed to a novel process for the preparation of protected L-alanine derivatives, useful as intermediates in the synthesis of compounds useful as mu/delta opioid modulators.
Type:
Grant
Filed:
September 5, 2014
Date of Patent:
November 17, 2015
Assignee:
Janssen Pharmaceutica NV
Inventors:
Luigi Anzalone, Penina Feibush, Frank J. Villani
Abstract: The present invention is directed to a novel process for the preparation of protected L-alanine derivatives, useful as intermediates in the synthesis of compounds useful as mu/delta opioid modulators.
Type:
Grant
Filed:
October 27, 2009
Date of Patent:
April 29, 2014
Assignee:
Janssen Pharmaceutica, N.V.
Inventors:
Luigi Anzalone, Penina Feibush, Frank J. Villani
Abstract: The invention relates to methods for carbon-carbon bond forming reactions, carbon-nitrogen bond forming reactions and/or carbon-oxygen bond forming reactions using phosphonium borate compounds represented by the Formula: (R1)(R2)(R3)PH.BAr4, wherein R1, R2, R3, and Ar4 are as defined herein in combination with a transition metal, transition metal salt, transition metal oxide or transition metal complex.
Abstract: Organozinc compounds of the type R1—Ar1—ZnY (1) can be reacted with different functionalized aryl halides R2—Ar2—X (2) in the presence of catalytic amounts of Ni or Fe in a polar solvent or solvent mixture to form polyfunctional biaryles of the type R1—Ar1—Ar2—R2 (3). Organozinc compounds of the type (1) can be represented by the transmetallation reaction of functionalized aryl magnesium halides or lithium aryl compounds with e.g. ZnBr2.
Type:
Application
Filed:
September 12, 2006
Publication date:
July 22, 2010
Inventors:
Paul knochel, Andrei Gavriushin, Christiane Charlotte Kofink, Georg Manolikakes
Abstract: The present invention is directed to a novel process for the preparation of protected L-alanine derivatives, useful as intermediates in the synthesis of compounds useful as mu/delta opioid modulators.
Type:
Application
Filed:
October 27, 2009
Publication date:
June 10, 2010
Inventors:
Luigi ANZALONE, Penina FEIBUSH, Frank J. VILLANI
Abstract: A 5-(3-cyanophenyl)-3-formylbenzoic acid compound of the formula (IV) is prepared by reacting a 5-bromo-3-(hydroxymethyl)benzoic acid compound of the formula (I) with manganese dioxide to provide a 5-bromo-3-formylbenzoic acid compound of the formula (II), and then reacting the resultant compound of the formula (II) with 3-cyanophenylboronic acid of the formula (III) in the presence of a palladium complex. R is a H atom or a C1-C10 alkyl group.
Abstract: The invention relates to a method for carrying out CC-coupling reactions, in particular a Heck and Suzuki reaction, in the presence of supported palladium as the catalyst and a base in a monophase or multiphase solvent mixture. According to said method, palladium detaches itself from the support in a characteristic manner, is redeposited after the reaction and the quantity of palladium not deposited after the reaction is significantly lower than 5000 ppm, in relation to the palladium used.
Type:
Application
Filed:
March 6, 2003
Publication date:
September 25, 2003
Inventors:
J?uuml;rgen Krauter, J?ouml;rg Pietsch, Peter Panster, Klaus Khler, Roland Heidenreich
Abstract: A catalyst comprising a mixed metal oxide is useful for the vapor phase oxidation of an alkane or a mixture of an alkane and an alkene to an unsaturated carboxylic acid and for the vapor phase ammoxidation of an alkane or a mixture of an alkane and an alkene to an unsaturated nitrile. The catalyst is treated with a source of hydrogen, an alcohol, a source of NOx or a mixture thereof.
Type:
Application
Filed:
October 17, 2002
Publication date:
July 17, 2003
Inventors:
Sanjay Chaturvedi, Anne Mae Gaffney, Dominique Hung Nhu Le
Abstract: The present invention relates to a process wherein heterogeneous finely dispersed palladium catalysts are used for cross coupling of alkenyl halides and boronic acids in the presence of base in an aprotic solvent to produce aryl- or heteroaryl-olefin compounds. The process provides for use with either electron-withdrawing or electron-donating substituents for cross coupling of alkyl halides with boronic acids.
Type:
Application
Filed:
July 16, 2001
Publication date:
April 18, 2002
Inventors:
Yongkui Sun, Carl LeBlond, John R. Sowa
Abstract: An improved process for the preparation of a cyclic amino acid by a novel synthesis is described where benzonitrile is treated with an alkali metal and an amine under Birch reduction conditions to generate in situ an anionic intermediate which is alkylated with an &agr;-haloacetic acid moiety which is subsequently converted to the desired product, as well as valuable intermediates used in the process.
Type:
Grant
Filed:
November 14, 2000
Date of Patent:
September 25, 2001
Assignee:
Warner-Lambert Company
Inventors:
Carl Francis Deering, Kenneth Earl Mennen, Robert Ramage
Abstract: 4-Chlorobiphenyls are prepared by reacting a haloaromatic with an aryl Grignard compound, where halogen is chlorine, bromine or iodine, in the presence of a palladium catalyst of the formula (IV) ##STR1##
Type:
Grant
Filed:
August 3, 1999
Date of Patent:
May 23, 2000
Assignee:
Clariant GmbH
Inventors:
Steffen Haber, Stefan Scherer, Andreas Meudt, Antje Noerenberg
Abstract: A method for producing an asymmetric biaryl derivative which comprises dehalogenocoupling halogenated benzene derivatives, wherein a bromobenzene derivative of the formula: ##STR1## wherein R is a lower alkyl group or a lower alkoxy group, which is attached at the 3- or 4-position, and a 2-chlorobenzene derivative of the formula: ##STR2## wherein R' is a cyano group or an alkoxycarbonyl group, are reacted in pyridine in the presence of triphenylphosphine, an anhydrous nickel compound and a reducing metal to obtain an asymmetric biaryl derivative of the formula: ##STR3## wherein R and R' are as defined above, and R is attached at the 3- or 4-position.
Abstract: Symmetrical diaryl-acetylenes can be prepared by reacting an aryl halide with acetylene in the presence of a palladium catalyst and a base. If the acetylene is introduced into the liquid reaction mixture using a high intensity gas dispersion means, the aryl halide used can be an aryl bromide.
Abstract: A process for preparing a perfluoroalkyl-substituted compound is disclosed. The process comprises reacting a halopolyfluoroalkane having 1 to 20 carbon atoms with a compound selected from the group consisting of (1) a substituted or unsubstituted ethylene, (2) a substituted or unsubstituted acetylene and (3) a substituted or unsubstituted allylsilane, in the presence of a metal-carbonyl complex of the metal of the Group VIII of the Periodic Table. Alternatively, the reaction between the halopolyfluoroalkane and the substituted or unsubstituted allylsilane is effected under radical generating condition.
Abstract: A process for preparing (polyfluoroalkyl)polyfluoroarenes comprising contacting a polyfluoroalkyl or perfluoroalkylene of specified formulae with a polyfluoroaromatic in the presence of at least one specified metal reagent is disclosed.
Abstract: 2-Isopropyl-2-(2-methylphenyl)-5-(N-methylhomoveratrylamino)-valeronitrile ("mepamil") of the Formula I: ##STR1## preferably administered in the form of water-soluble acid addition salts such as e.g. hydrochloride. The claimed compound is advantageously prepared by alkylation of 2-(2-methylphenyl)-3-methylbutyronitrile with 3,3-diethoxypropylchloride. Subsequently, the obtained 5,5-diethoxy-2-isopropyl-2-(2-Methylphenyl)-valeronitrile is mildly, acidically hydrolisized to yield the appropriate aldehye, i.e. 2-isopropyl-2-(2-methylphenyl)-5-oxovaleronitrile. This aldehyde is then reacted with N-methylhomoveratrylamine under conditions of reductive alkylation, suitably by catalytic hydrogenation over a platinum or palladium catalyst or by chemical reduction with the use of formic acid as a reducing agent. The resulting base is optionally converted by neutralization with a pharmaceutically acceptable organic or inorganic acid, i.e. hydrochloric or fumaric acid, into the corresponding acid addition salt.
Type:
Grant
Filed:
July 17, 1987
Date of Patent:
July 11, 1989
Assignee:
Spofa, spojene podniky pro zdravotnickou
Inventors:
Luedvik Blaha, Miroslav Rajsner, Ivan Helfert, Vaclav Trcka